Terumo BCT, Inc.

Terumo BCT, Inc. is a division of Terumo Corporation and a global leader in blood management, blood and cell therapies, and related healthcare solutions. Headquartered in Lakewood, Colorado, Terumo BCT operates as the Blood Management Company within the Terumo Group, serving over 130 countries and regions worldwide. The company develops, manufactures, and distributes medical devices and consumables for blood transfusion management, hemapheresis, cell therapy processing, and related clinical applications. Terumo BCT specializes in automated blood collection, processing, testing, and therapeutic apheresis technologies. The company's product portfolio includes blood management systems, cell and gene therapy manufacturing solutions, and diagnostic equipment for blood banking and transfusion medicine. Terumo BCT maintains regulatory compliance with FDA, ISO 13485, and CE marking requirements. The company operates manufacturing facilities in North America and maintains a robust distribution and service infrastructure supporting hospitals, blood banks, and healthcare institutions globally. As part of the larger Terumo Group, which generated approximately 35% of group sales from North American operations, Terumo BCT represents a significant strategic asset in cellular and blood-based therapeutic innovation and clinical implementation.